TFRC and peripheral neuropathy: Peripheral neuropathy and neuropathic pain remain important and treatment-limiting side effects for PWH who are treated with older drugs such as stavudine, as well as for PWH receiving protease inhibitors and other non-NRTI-based regimens [18, 20]; further studies should explore the influence of sTFR levels, estimated body iron stores, and HFE variants in these populations.